Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pivotal phase III trial of Nabi-StaphVAX now under way

April 6, 1998

NIH offers malaria vaccine technology for licensing

April 3, 1998

Zenapax launched in Switzerland

March 17, 1998

Immunosuppressive analogues of a natural immunostimulant

March 16, 1998

New malaria vaccine described in patent literature

March 16, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Alliance formed for development of oral vaccines from plants

March 11, 1998

PGG-glucan displays potent protective effects in guinea pig model

March 10, 1998

PowderJect and Glaxo Wellcome enter DNA vaccine collaboration

March 10, 1998

Boston Life Sciences licenses BCLx-gamma gene from Harvard

March 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...